| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.03B | 112.09B | 106.62B | 107.38B | 97.75B | 91.94B |
| Gross Profit | 25.78B | 28.63B | 25.58B | 26.65B | 21.75B | 20.72B |
| EBITDA | 9.07B | 12.94B | 8.66B | 10.68B | 7.19B | 6.98B |
| Net Income | 4.20B | 6.60B | 3.82B | 4.67B | 2.92B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 110.54B | 120.32B | 113.65B | 116.63B | 106.32B | 100.24B |
| Cash, Cash Equivalents and Short-Term Investments | 16.38B | 16.56B | 13.43B | 15.47B | 10.66B | 12.45B |
| Total Debt | 3.12B | 2.40B | 3.71B | 5.54B | 3.29B | 4.60B |
| Total Liabilities | 43.80B | 46.56B | 47.19B | 52.78B | 47.86B | 44.68B |
| Stockholders Equity | 61.43B | 67.93B | 60.97B | 58.25B | 53.78B | 51.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.74B | 1.03B | 3.57B | 151.00M | 2.72B |
| Operating Cash Flow | 0.00 | 10.78B | 5.04B | 5.94B | 2.25B | 4.14B |
| Investing Cash Flow | 0.00 | -5.05B | -3.75B | -2.31B | -1.92B | -1.46B |
| Financing Cash Flow | 0.00 | -2.60B | -3.35B | 1.18B | -2.20B | -5.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥119.95B | 7.55 | ― | 1.61% | 5.13% | 72.55% | |
77 Outperform | ¥271.15B | 13.32 | ― | 1.53% | 9.71% | 54.82% | |
76 Outperform | ¥2.19T | 7.87 | 12.05% | 1.50% | 9.27% | 3.50% | |
74 Outperform | ¥128.74B | 7.89 | 8.07% | 2.64% | 81.06% | 65.92% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥56.10B | -60.12 | ― | 5.01% | -25.54% | -166.77% | |
58 Neutral | ¥44.36B | 11.47 | ― | 0.91% | 11.44% | -4.29% |